Results 21 to 30 of about 45,205 (210)
The potential of androgenic alopecia management from plant derivative [PDF]
, 2020 Hair loss or alopecia is a common dermatological issue that can affect millions of human population of all ages and both gender, male and female. Frequently, alopecia has been found to be associated with significant adverse effects or reduction of ...
Mohamad Salam, N. A. +11 more
core +1 more source
Pakistan Armed Forces Medical Journal, 2022 Objective: To compare the effect of topical liquid Nitrogen and normal saline on pain during intradermal Platelet-rich Plasma therapy in androgenic alopecia. Study Design: Prospective Comparative study.
Moizza Tahir +5 more
doaj +1 more source
The Importance of Vitamin-D in Androgenic Alopecia and Telogen Effluvium [PDF]
Ķazaķstannyṇ Klinikalyķ Medicinasy, 2018 Aim: Androgenic alopecia (AA) is defined as progressive miniaturization of scarless hair follicle prevailing among both male and female. Telogen effluvium (TE) is the most common hair loss form accompanying systemic diseases.
Gülbahar Saraç, Tuba Tülay Koca
doaj +1 more source
Efficacy of Nano fat versus Non-Enzymatic Stromal Vascular Fraction in the Treatment of Androgenetic Alopecia. [PDF]
Al-Azhar International Medical Journal, 2022 Background: Androgenic alopecia is a common condition that is defined by the progressive conversion of terminal hairs to villus hairs in a unique distribution in both males and females.
Mahamed El-khalawany +2 more
doaj +1 more source
Metabolic syndrome in androgenic alopecia
Indian Journal of Dermatology, Venereology, and Leprology, 2016 Androgenic alopecia has been associated with an increased risk of coronary heart disease in various studies. The relationship between androgenic alopecia and metabolic syndrome, a known risk factor for atherosclerotic cardiovascular disease, is still poorly understood.To study the association between metabolic syndrome and early-onset androgenic ...
Hima, Gopinath, Gatha M, Upadya
openaire +2 more sources
Trichology features of alopecia in reproductive age women with polycystic ovary syndrome
Acta Biomedica Scientifica, 2017 Background. Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting 5-10 % of reproductive-aged women. The dermatologic manifestations of PCOS play a significant role in diagnosis. The purpose of the present study was to
L. V. Belenkaya +4 more
doaj +1 more source
Future Journal of Pharmaceutical Sciences, 2022 Background Melatonin (MEL) is a powerful antioxidant molecule with anti-androgenic property. A microemulsion (ME) system loaded with MEL was designed for treatment of androgenic alopecia. Pseudo-ternary phase diagram was constructed, and ME formulae were
Asmaa A. Elshall +4 more
doaj +1 more source
Molecules, 2022 There is a growing demand for hair loss treatments with minimal side effects and recurrence potential. Connarus semidecandrus Jack has been used as a folk medicine for fever in tropical regions, but its anti-alopecia effects remain unclear. In this study,
Won Young Jang +12 more
doaj +1 more source
Androgenic alopecia in post-menopausal female: a clinical presentation [PDF]
, 2020 Androgenic alopecia is a patterned hair loss occurring due to systemic androgens and genetic factors. It is the most common cause of hair loss in both genders. The appearance of this condition is the cause of significant stress and psychological problems,
Arya, Vivek +5 more
core +1 more source
Male androgenic alopecia frequency by age group.
, 2013 Male androgenic alopecia frequency by age group.
Chu-Ting Chang (503325) +13 more
core +1 more source